vs
Side-by-side financial comparison of SS Innovations International, Inc. (SSII) and UPEXI, INC. (UPXI). Click either name above to swap in a different company.
SS Innovations International, Inc. is the larger business by last-quarter revenue ($14.5M vs $8.1M, roughly 1.8× UPEXI, INC.). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -2222.1%, a 2205.1% gap on every dollar of revenue. On growth, UPEXI, INC. posted the faster year-over-year revenue change (101.0% vs 79.1%). UPEXI, INC. produced more free cash flow last quarter ($-2.7M vs $-3.2M). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 24.2%).
SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.
SSII vs UPXI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $14.5M | $8.1M |
| Net Profit | $-2.5M | $-178.9M |
| Gross Margin | 43.9% | 83.3% |
| Operating Margin | -3.7% | -2177.9% |
| Net Margin | -17.0% | -2222.1% |
| Revenue YoY | 79.1% | 101.0% |
| Net Profit YoY | -28.5% | -13649.6% |
| EPS (diluted) | $-0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.5M | $8.1M | ||
| Q3 25 | $12.8M | $9.2M | ||
| Q2 25 | $10.0M | $4.3M | ||
| Q1 25 | $5.1M | $3.2M | ||
| Q4 24 | $8.1M | $4.0M | ||
| Q3 24 | $4.4M | $4.4M | ||
| Q2 24 | $4.5M | $5.0M | ||
| Q1 24 | $3.6M | $5.2M |
| Q4 25 | $-2.5M | $-178.9M | ||
| Q3 25 | $-3.7M | $66.7M | ||
| Q2 25 | $-256.7K | $-6.9M | ||
| Q1 25 | $-5.7M | $-3.8M | ||
| Q4 24 | $-1.9M | $-1.3M | ||
| Q3 24 | $-3.2M | $-1.6M | ||
| Q2 24 | $-4.1M | $-15.7M | ||
| Q1 24 | $-9.8M | $-4.1M |
| Q4 25 | 43.9% | 83.3% | ||
| Q3 25 | 48.1% | 89.6% | ||
| Q2 25 | 59.1% | 79.4% | ||
| Q1 25 | 21.2% | 49.3% | ||
| Q4 24 | 48.9% | 74.3% | ||
| Q3 24 | 52.8% | 67.3% | ||
| Q2 24 | 31.9% | 31.0% | ||
| Q1 24 | 20.0% | 24.3% |
| Q4 25 | -3.7% | -2177.9% | ||
| Q3 25 | -14.3% | — | ||
| Q2 25 | 1.0% | -151.7% | ||
| Q1 25 | -115.6% | -113.5% | ||
| Q4 24 | -22.7% | -26.8% | ||
| Q3 24 | -73.1% | -30.6% | ||
| Q2 24 | -90.9% | -265.2% | ||
| Q1 24 | -270.3% | -96.5% |
| Q4 25 | -17.0% | -2222.1% | ||
| Q3 25 | -29.0% | 722.4% | ||
| Q2 25 | -2.6% | -161.5% | ||
| Q1 25 | -111.0% | -121.2% | ||
| Q4 24 | -23.7% | -32.5% | ||
| Q3 24 | -74.0% | -37.3% | ||
| Q2 24 | -91.8% | -312.4% | ||
| Q1 24 | -270.5% | -78.9% |
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $-0.02 | $0.76 | ||
| Q2 25 | $0.00 | $0.83 | ||
| Q1 25 | $-0.03 | $-2.87 | ||
| Q4 24 | $-0.01 | $-1.24 | ||
| Q3 24 | $-0.02 | $1.55 | ||
| Q2 24 | $-0.02 | $-15.66 | ||
| Q1 24 | $-0.06 | $-4.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.2M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $38.2M | $48.7M |
| Total Assets | $74.2M | $271.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | — | ||
| Q3 25 | $5.7M | — | ||
| Q2 25 | $11.4M | — | ||
| Q1 25 | $15.9M | — | ||
| Q4 24 | $466.5K | — | ||
| Q3 24 | $220.4K | — | ||
| Q2 24 | $608.2K | — | ||
| Q1 24 | $948.1K | — |
| Q4 25 | $38.2M | $48.7M | ||
| Q3 25 | $39.6M | $210.8M | ||
| Q2 25 | $42.0M | $90.1M | ||
| Q1 25 | $40.6M | $1.9M | ||
| Q4 24 | $13.5M | $3.8M | ||
| Q3 24 | $13.7M | $5.0M | ||
| Q2 24 | $14.8M | $6.5M | ||
| Q1 24 | $16.7M | $22.1M |
| Q4 25 | $74.2M | $271.1M | ||
| Q3 25 | $69.6M | $419.7M | ||
| Q2 25 | $70.0M | $123.8M | ||
| Q1 25 | $63.5M | $15.1M | ||
| Q4 24 | $42.4M | $17.5M | ||
| Q3 24 | $39.0M | $18.6M | ||
| Q2 24 | $35.7M | $23.5M | ||
| Q1 24 | $35.2M | $56.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.5M | $-2.7M |
| Free Cash FlowOCF − Capex | $-3.2M | $-2.7M |
| FCF MarginFCF / Revenue | -22.3% | -33.5% |
| Capex IntensityCapex / Revenue | 11.8% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-22.2M | $-22.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.5M | $-2.7M | ||
| Q3 25 | $-7.5M | $-9.8M | ||
| Q2 25 | $-3.5M | $-8.4M | ||
| Q1 25 | $-6.1M | $-778.7K | ||
| Q4 24 | $-3.3M | $-1.4M | ||
| Q3 24 | $-2.5M | $-2.0M | ||
| Q2 24 | $-1.0M | $-101.4K | ||
| Q1 24 | $-2.7M | $783.5K |
| Q4 25 | $-3.2M | $-2.7M | ||
| Q3 25 | $-8.2M | $-9.8M | ||
| Q2 25 | $-3.8M | $-8.8M | ||
| Q1 25 | $-7.0M | $-809.3K | ||
| Q4 24 | $-3.4M | — | ||
| Q3 24 | $-4.2M | $-2.1M | ||
| Q2 24 | $-3.1M | $-1.0M | ||
| Q1 24 | $-2.8M | $600.9K |
| Q4 25 | -22.3% | -33.5% | ||
| Q3 25 | -64.1% | -106.0% | ||
| Q2 25 | -37.7% | -205.4% | ||
| Q1 25 | -136.2% | -25.6% | ||
| Q4 24 | -41.7% | — | ||
| Q3 24 | -96.9% | -49.2% | ||
| Q2 24 | -69.5% | -20.5% | ||
| Q1 24 | -76.9% | 11.5% |
| Q4 25 | 11.8% | 0.2% | ||
| Q3 25 | 5.9% | 0.2% | ||
| Q2 25 | 3.2% | 9.0% | ||
| Q1 25 | 17.0% | 1.0% | ||
| Q4 24 | 1.5% | 0.0% | ||
| Q3 24 | 38.8% | 3.8% | ||
| Q2 24 | 46.8% | 18.5% | ||
| Q1 24 | 3.5% | 3.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SSII
| System Sales | $13.4M | 92% |
| Other | $1.2M | 8% |
UPXI
Segment breakdown not available.
